Top Research Reports for Novo Nordisk, AstraZeneca & Accenture
Todays Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and…
126,150€
2,60%
Echtzeit-Aktienkurs AstraZeneca PLC
Bid:
Ask:
Nachrichten zur AstraZeneca PLC Aktie
ADRs End Higher, AstraZeneca and Carnival Trade Actively
ADRs End Higher, AstraZeneca and Carnival Trade Actively...…
AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs
The European Commission approves AstraZenecas (AZN) two key cancer drugs Lynparza and Imfinzi for expanded use....…
AstraZeneca has two of its cancer drugs approved for use in the EU
The FTSE 100 pharma giant said Imfinzi has been given the green light in the EU for the treatment of…
Form 6-K ASTRAZENECA PLC For: Dec 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca wins two new approvals in EU for cancer drugs
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Imfinzi combo for biliary tract cancer gets approval in EU
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: Imfinzi Combination Approved In EU For Advanced Biliary Tract Cancer Treatment
LONDON (dpa-AFX) - British drug major AstraZeneca Plc.s (AZN.L, AZN) Imfinzi (durvalumab) has been approved in the European Union for…
AstraZeneca: Lynparza In Combination With Abiraterone Approved In EU For Prostate Cancer
LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L), on Wednesday, announced that Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone…
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health – Abu…
Astrazeneca (AZN) Stock Moves -0.69%: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $67.47, moving -0.69% from the previous trading session....…
ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively
ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively...…
AstraZeneca posts mixed results from lung cancer trial
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K ASTRAZENECA PLC For: Dec 19
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Drug Imfinzi Fails As Monotherapy In Metastatic Lung Cancer Setting
read more...…
TOP NEWS: AstraZeneca receives host of EU approvals or recommendations
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: Enhertu Gets CHMP Recommendation For EU Approval For HER2-low Metastatic Breast Cancer
LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Medicines Agencys Committee for Medicinal…
AstraZeneca Says Enhertu Approved In EU To Treat Advanced HER2-positive Gastric Cancer.
LONDON (dpa-AFX) - AstraZeneca (AZN.L) on Monday said Enhertu, jointly developed by AstraZeneca and Daiichi Sankyo, has been approved in…
AstraZeneca: CHMP Recommends Imfinzi And Imjudo Combinations For Advanced Liver And Lung Cancers
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said the Committee for Medicinal Products for Human Use of the European Medicines Agency…
UPDATE 1-AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer
...(Adds details, background)
Dec 19 (Reuters) - AstraZeneca said......…
EU-Zulassungsempfehlung für Astrazeneca-Kombination Imfinzi-Imjudo
Von Anthony O. Goriainoff LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat für eine Kombinationstherapie seiner Krebsmittel Imfinzi und Imjudo eine…
FTSE News: Joules Shares Canceled, AstraZeneca Trial Results ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca says Imfinzi fails as monotherapy for type of lung cancer
...Dec 19 (Reuters) - AstraZeneca said on Monday
its drug Imfinzi failed......…
AstraZeneca: Imfinzi Fails To Meet Statistical Significance For Primary Goals In PEARL Trial
LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Monday that Imfinzi (durvalumab) did not achieve statistical significance…
Astrazeneca erhält EU-Zulassungempfehlung für Herzmittel Forxiga
Von Anthony O. Goriainoff LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat für sein Medikament Forxiga in der EU eine Zulassungsempfehlung…
AstraZeneca: CHMP Recommends Forxiga For Approval In Adults For Treatment Of Symptomatic Chronic HF
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said its Forxiga has been recommended for approval in the European Union to extend…
Update on Imfinzi PEARL trial
19 December 2022 07:05 GMT
Update on PEARL Phase III trial of Imfinzi monotherapy
in Stage IV non-small cell lung cancer
The PEARL Phase III…
Implied Volatility Surging for AstraZeneca (AZN) Stock Options
Investors need to pay close attention to AstraZeneca (AZN) stock based on the movements in the options market lately....…
Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date
Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date...…
Form 6-K ASTRAZENECA PLC For: Dec 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca
Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca have been highlighted in this Industry Outlook article....…
AstraZeneca and Merck receive US FDA extension for Lynparza review
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: FDA To Extend PDUFA Date Regarding SNDA For Lynparza With Abiraterone
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) and MSD announced the FDA has informed AstraZeneca that it will extend the PDUFA…
Update on US review of Lynparza PROpel sNDA
15 December 2022 07:00 GMT
Update on US regulatory priority review of Lynparza in combination with
abiraterone in metastatic castration-resistant prostate cancer
AstraZeneca and MSD today…
Astrazeneca (AZN) is a Top-Ranked Value Stock: Should You Buy?
Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…
ADRs End Lower; AstraZeneca, British American Tobacco Trade Actively
ADRs End Lower; AstraZeneca, British American Tobacco Trade Actively...…
UPDATE 1-Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
...(Adds AstraZeneca comment)
By Nancy Lapid
Dec 9 (Reuters) - The rush......…
Daiichi and AstraZeneca hail promising breast cancer treatment results
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: Datopotamab Deruxtecan Shows Encouraging Objective Response Rate In Phase I Trial
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said the updated results from the TROPION-PanTumor01 Phase I trial showed datopotamab deruxtecan continued…
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
...By Nancy Lapid
(Reuters) - The rush to use AstraZeneca......…
CORRECT: AstraZeneca cancer drug shows encouraging results in trial
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca cancer drug shows encouraging results in phase 1 trial
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca says adding to capivasertib to Faslodex reduces breast cancer progression
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
TOP NEWS: AstraZeneca hails breast cancer drug trial results
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K ASTRAZENECA PLC For: Dec 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Reports Positive Survival In Phase 3 Trial Of ENHERTU In HER2 Metastatic Breast Cancer
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) Wednesday announced that ENHERTU, a HER2-directed antibody-drug conjugate or ADC, achieved statistically significant overall…
BioStock: Iconovo establishes Nordic pharmaceutical sales
Iconovo has started building up the subsidiary Iconovo Pharma, which will sell and market pharmaceuticals in the Nordic region. Inhalation…
Form 6-K ASTRAZENECA PLC For: Dec 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Total Voting Rights
1 December 2022 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal
The acquisition of Neogene is set to give AstraZeneca (AZN) access to the latters next-generation T-cell receptor therapies....…